Photodynamic therapy trial expands.
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008029:Lighting; D008187:Lutetium / Q000008:administration & dosage*; D008297:Male; D008665:Metalloporphyrins / Q000008:administration & dosage*; D009369:Neoplasms / Q000188:drug therapy*; D010778:Photochemotherapy; D017319:Photosensitizing Agents / Q000008:administration & dosage*; D012514:Sarcoma, Kaposi / Q000188:drug therapy / Q000209:etiology
D008665:Metalloporphyrins; D017319:Photosensitizing Agents; C102825:motexafin lutetium; D008187:Lutetium; C437683:motexafin gadolinium